05Dec
03Dec
With community’s help, legally blind Springfield teen now can see world through new electronic glasses
Reilly Gault, 15, has been legally blind for the majority of his life. But on Friday evening, that all changed — Gault now can see. Gault, 15, recently asked the community for some help to raise $10,000 so he could purchase computerized glasses that allow him to see the world through a new and clearer lens. The community responded with a resounding “yes” and donated more than enough to cover the cost of the electronic glasses, made by Canadian-based company eSight. Read...
02Dec
Just the Facts on Myomo, Inc. (MYO)
Myomo, Inc. (MYO) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has been active on the tape, currently trading at $2.21, down from yesterday’s close by -24.04%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data. Read more >>
01Dec
Myomo, Inc. Announces Pricing of Public Offering
Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company, today announced that it has priced an underwritten public offering of 4,175,000 shares of its common stock and accompanying warrants to purchase 4,175,000 shares of common stock. Each share of common stock is being sold together with one warrant to purchase one share of common stock, at a combined price to the public of $2.40 per share of common stock and accompanying warrant, for gross proceeds of approximately $10.0...
30Nov
Myomo Expands MyoPro® Centers of Excellence Program
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the addition of six new orthotics and prosthetics (O&P) locations to its Center of Excellence (CoE) program, which recognizes top O&P practices that support the MyoPro line of powered orthoses. MyoPro is currently the only lightweight wearable device that can help restore function in the paralyzed or weakened arms and hands of individuals who have suffered a stroke, brachial plexus injury (BPI) or...
29Nov
Myomo, Inc. to Present at the 10th Annual LD Micro Main Event
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will be presenting at the 10th annual LD Micro Main Event on Tuesday, December 5th at 9:30 AM PST / 12:30 PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Chairman and Chief Executive Officer Paul R. Gudonis will be presenting, as well as meeting with investors. Read more >>
28Nov
Corbus Pharmaceuticals Expands Intellectual Property Portfolio with Patent Issuance Covering the Use of Anabasum for the Treatment of Rare Fibrotic Diseases
Corbus Pharmaceuticals Holdings, Inc., a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Patent No. 9,820,964 to the Company with claims covering the use of pharmaceutical compositions comprising anabasum for the treatment of multiple fibrotic diseases, including the Company's lead indications: systemic sclerosis, dermatomyositis, cystic fibrosis as well as others. Read more >>
26Nov
Middleton Samaritan hopes to see again
After stopping to help someone on the freeway, and getting hit himself, Jamie Harrell spent about two months in the hospital. He is recovering now but hopes to see again after the accident left him legally blind. Jamie and Nena are now trying to raise funds to be able to buy eSight glasses which will help him see again. Read more >>
24Nov
A Wearable Tech Miracle For the Legally Blind
For Conrad Lewis, the founder of eSight, the project is close to the heart. Lewis grew up with two legally blind sisters. He studied engineering and was determined to utilize his knowledge to create glasses that could improve his sisters’ vision. After years of research, multiple patented innovations, tens of millions of dollars, and clinical tests on legally blind people, Lewis’ miracle glasses are now available to everyone. Read more >>
23Nov